Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gene-corrected regulatory T cell therapy for IL2RA deficiency

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.004Source: DataRank Database

Gene-corrected regulatory T cell therapy for IL2RA deficiency is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.73)OA: greenTopics (29)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Nechama Kalter ORCID,Michael A. Rosenberg ORCID,Luis A. Acevedo,Brianna Liang,Weihong Liu ORCID

Live enrichment

PubMed:41376159 OpenAlex:https://openalex.org/W4417178158

National Institutes of Health

Grant: P30 DK063720

National Institutes of Health

Grant: S10 1S10OD021822\u201301

National Institutes of Health

Grant: S10 1S10OD026940-01

National Institutes of Health

Grant: S10 1S10OD018040-01

Diabetes Center, University of California, San Francisco

Grant: SCR_018206

NCATS NIH HHS

Grant: L30 TR002983

NCI NIH HHS

Grant: K08 CA273529

University of California, San Francisco

Innovative Genomics Institute

FWCI

0.73

Citation Percentile

0.7%

Citation Trend

2026

greenLicense: cc-by-nc-nd

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12974163/

publisherhttps://api.elsevier.com/content/article/PII:S1525001625010275?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625010275?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2025.12.004

Fields of Study

Immunodeficiency and Autoimmune DisordersT-cell and B-cell ImmunologyDiabetes and associated disorders

MeSH Terms

Gene EditingFemaleHumansInterleukin-2MaleMutationGenetic TherapyT-Lymphocytes, RegulatoryInterleukin-2 Receptor alpha SubunitCRISPR-Cas Systems

Keywords

Regulatory T cellGenetic enhancementHaematopoiesisT cellHematopoietic stem cell transplantationStem cellMutationDiseaseGene correctionRegulatory T cellsCrisprRare DiseaseNon-viralIl2raInborn Errors Of ImmunityClinical Manufacturing